DAXOR CORP (DXR): Submission of Matters to a Vote of Security Holders
DAXOR CORP (DXR) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0000027367 0000027367 2026-06-23 2026-06-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Repor
How this was made
The 30-second read
Why it matters
Director elections were approved with specified vote counts; shareholders also ratified Bush & Associates, CPA as independent registered public accounting firm. No new business terms, clinical/regulatory milestones, or financial guidance are included.
Market read
This is a procedural governance disclosure; it mainly updates corporate control/auditor status rather than changing fundamentals.
What to watch
The only potentially actionable item is auditor ratification, which is typically procedural and rarely changes near-term risk/earnings expectations.
Background
The SEC Form 8-K (Item 5.07) summarizes matters voted on at Daxor’s June 23, 2026 annual meeting.
Ticker impact
Daxor’s 8-K reports June 23, 2026 annual meeting results, including director elections and ratification of its independent auditor.
Low likelihood of a sustained price move based solely on this 8-K; any reaction would be limited to governance/auditor housekeeping.
Item 5.07 only summarizes voting outcomes (board elections and auditor ratification) without new operating or financial datapoints.
Market effects
Minimal; no change to medical diagnostics/biotech competitive landscape is disclosed.
Minimal; Nasdaq-listed microcap governance update only.
Minimal; no cross-border transaction or regulatory action mentioned.
Counterpoint
Traders could still monitor for follow-on filings (e.g., subsequent 10-Q/8-K) if board changes signal strategic shifts, but this specific document does not provide that signal.
Key entities
- companyDaxor Corporation
Nasdaq-listed medical instrumentation/biotechnology company; subject of the 8-K voting results.
- auditorBush & Associates, CPA
Independent registered public accounting firm ratified by shareholders at the annual meeting.



